Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt 21/03/2012 by William New, Intellectual Property Watch 4 Comments Word is spreading of a recent decision by a Brazilian judge to annul a patent on a key AIDS drug, effectively allowing less expensive generic versions into the country, and calling into question other such patents.
Take The Brussels University Survey On Beliefs About IP 15/03/2012 by Intellectual Property Watch Leave a Comment The Free University of Brussels has set out to map predominant normative and causal beliefs regarding IP laws and policies. To give your input and participate in the survey, click on www.surveymonkey.com/s/IP_Community.
Intérêt de l’entreprise et choix stratégiques : les licences concédées par Gilead au Medicines Patent Pool 14/03/2012 by Intellectual Property Watch Leave a Comment Bien que Gilead ait apporté des améliorations considérables à ses précédentes licences volontaires portant sur des médicaments antirétroviraux essentiels, les licences que l’entreprise a concédées au Medicines Patent Pool, fondation créée par UNITAID, comportent des restrictions regrettables qui fragilisent leur impact sur l’accès à des antirétroviraux génériques de qualité garantie plus abordables dans les pays en développement.
WIPO To Discuss Role Of Patents In Access To Water 14/03/2012 by Intellectual Property Watch 1 Comment The World Intellectual Property Organization has waded into the global debates over access to safe drinking water, with an upcoming workshop on patents and water purification technologies.
Ukraine WTO Trademark Dispute Vs. Australia Tests Public Health Measures 14/03/2012 by William New, Intellectual Property Watch 3 Comments Ukraine yesterday filed a World Trade Organization dispute settlement case against Australia for its 2011 law requiring plain packaging on tobacco in an effort to address the severe public health problem related to its use. The case could represent an important measure of the power of trade interests versus public health decisions by governments.
WHO Under Siege By Private Sector, Group Asserts 13/03/2012 by Intellectual Property Watch Leave a Comment The World Health Organization is under siege by private sector forces using their financial leverage to gain undue influence in the financially beleaguered United Nations agency, a developing country-oriented group has said.
India Grants First Compulsory Licence, For Bayer Cancer Drug 12/03/2012 by Maricel Estavillo for Intellectual Property Watch 8 Comments In a move welcomed by many in the international community, India has granted an application, its first, from a homegrown generic drug maker to manufacture and sell a patented cancer drug under a compulsory licence.
European Parliament Hears Pitch For ACTA; But Did It Change Minds? 02/03/2012 by Dugie Standeford for Intellectual Property Watch 1 Comment The controversial Anti-Counterfeiting Trade Agreement consumed hours of European Parliament time this week as the European Commission sought to persuade lawmakers to approve it. But no matter how often EC officials, academics and lawyers said the treaty will not change EU law, scepticism still remains about its potential impact on digital freedoms and access to generic medicines in developing countries – including from the Parliament member who will author the legislative report.
Novartis Before India’s Supreme Court: What’s Really At Stake? 02/03/2012 by Rachel Marusak Hermann, Intellectual Property Watch 3 Comments As the Novartis Glivec patent case in India reaches the final phase of a long-running legal battle, there’s one point on which both the Swiss pharmaceutical company and its critics agree: the significance of this case goes far beyond the protection of a single medication.
ACTA Debated At WTO; Petitions And Letters Fly In Brussels 29/02/2012 by William New, Intellectual Property Watch 2 Comments While action on the Anti-Counterfeiting Trade Agreement is occurring at the European Parliament in Brussels – including a new letter from Members of Parliament and 2.5 million petitioners in opposition – ACTA also was the subject of discussion at the World Trade Organization this week.